INSM
Insmed, Inc.
stockNASDAQ
At CloseOct 21, 2026 3:59:59 PM EDT
94.09USD-1.652%(-1.58)2,939,874
Pre-marketOct 21, 2026 8:01:30 AM EDT
95.30USD-0.387%(-0.37)
After-hoursOct 21, 2026 4:36:30 PM EDT
94.04USD-0.053%(-0.05)
Loading…
Loading…
20.55B
Healthcare
Biotechnology
CEO
William Lewis
HQ
Bridgewater, NJ, USA
214
Previous Close
$95.67
Beta
0.52
52-Week High
$212.75 2025-12-02
52-Week Low
$90.39 2026-06-10
SMA 50
$117.37
SMA 200
$128.29
Avg. Vol 10D
2.86M
Avg. Vol 30D
2.68M
Avg. Vol 90D
2.98M
Relative Vol
0.74
218.38M
215.15M
98.52%
13,800,693
6.96%
6.50
53%/47%
36.47%
33.66%
0.3900%
5,400,000
30
842
3,154
Oct 29, 2026 (7d)
Mar 3, 2011 · 1-for-10 (reverse)
1.1B
-875.3M
-4.08
-807.7M
-73.89
-87.22
Oct 19, 2026
Insmed launches bronchiectasis treatment in Japan · 
Investing.com
Oct 15, 2026
Insmed launches four phase 3 trials for lung disease therapy · Investing.com
INSM Profile
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients' lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
INSM Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 97.79 | 2026-10-14 | -3.75% | 2.106 |
| 1M | 121.00 | 2026-09-21 | -22.21% | 0.110 |
| 3M | 108.62 | 2026-07-21 | -13.35% | -0.032 |
| 6M | 140.98 | 2026-04-21 | -33.24% | 0.690 |
| 1Y | 165.31 | 2025-10-21 | -43.06% | 0.524 |
| 2Y | 72.28 | 2024-10-21 | +30.22% | — |
| 5Y | 27.52 | 2021-10-21 | +242.01% | 0.966 |
INSM Stock Summary
Insmed, Inc. (NASDAQ:INSM) stock price today is $94.12, and today's volume is 1,978,623. INSM is down 1.620% today. The 30 day average volume is 2.68M. INSM market cap is $20.55B with 218.38M shares outstanding.